Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michalina Adamski is active.

Publication


Featured researches published by Michalina Adamski.


Medical Microbiology and Immunology | 1990

Anti-human immunodeficiency virus (HIV) drug HOE/BAY 946 increases membrane hydrophobicity of human lymphocytes and specifically suppresses HIV-protein synthesis

Lothar Biesert; Michalina Adamski; Guido Zimmer; Hary Suhartono; Jürgen Fuchs; Uwe Unkelbach; Rolf J. Mehlhorn; Katman Hideg; R. Milbradt; Helga Rübsamen-Waigmann

The polysulfated polyxylan HOE/BAY 946, which has been tested in two pilot studies in ARC/AIDS patients and in asymptomatic HIV carriers in Germany, was believed to act by inhibiting virus attachment to the cell. However, the drug was also found to reduce the amount of HIV particles released from infected peripheral blood mononuclear cells (PBMC) in vitro. Furthermore, preincubation of PBMC with the drug led to a partial inhibition of a following HIV infection, suggesting that the drug also affects virus entry. Electron Paramagnetic Resonance (EPR) measurements on uninfected human lymphocytes using 5-proxyl-nonane as spin label demonstrated smaller hyperfine coupling constant (aN) values in the presence of HOE/BAY 946 or dextran sulfate 5000. Accordingly, h-1P/h-1H ratios were decreased, indicating increased plasma membrane hydrophobicity and a membrane-stabilizing effect of the drugs. Culture of the chronically HIV-infected monocytic cell line U937/HIV-2D194 in the presence of HOE/BAY 946 specifically and drastically reduced the release of virions and the intracellular synthesis of viral proteins as determined by radioimmunoprecipitation and reverse transcriptase assays. In conclusion, although the EPR studies showed a physico-chemical effect on membrane polarity, HOE/BAY 946 and dextran sulfate clearly affect processes beyond the cell membrane. Thus, in contrast to previous reports suggesting that polysulfated sugars affect HIV only by inhibiting virus binding to uninfected cells, they clearly inhibit HIV in infected cells as well and appear to have a pleiotropic mode of action. Such drugs may be less likely to result in viral resistance after prolonged application than substances acting only on one step in the life cycle of the virus.


Research in Virology | 1990

Molecular cloning of two west African HIV2 isolates that replicate well in macrophages

Herbert Kühnel; H. von Briesen; Ursula Dr Dietrich; C. Meichsner; Michalina Adamski; R Kreutz; A Seipp; H. Rübsamen-Waigmann

HIV2 strains were isolated from a Gambian with neuro-AIDS (HIV2D194) and from an asymptomatic Ghanian (HIV2D205). Like HIV1 biological subtype c, both isolates grew slowly and induced few or no syncytia, but eventually produced high levels of particle-associated reverse transcriptase (RT) in cultures of fresh peripheral blood lymphocytes. Each produced even higher levels of RT in fresh human macrophages, especially HIV2D194, where maximal RT values of 1,800,000 cpm/ml supernatant of approximately 30,000 cells were measured. The viruses were molecularly cloned after a single passage in culture. Restriction site analysis showed heterogeneity within each isolate. Nucleotide sequence analysis of HIV2D194 revealed that, genetically, it is a member of the prototypic HIV2 family, displaying 12% divergence vs. HIV2ROD and HIV2NIHZ. In contrast, HIV2D205 is the most highly divergent HIV2 strain yet described: it is equidistant in relation between the known HIV2 strains and the SIVMAC isolates (23-24% nucleotide sequence divergence).


Proceedings of the National Academy of Sciences of the United States of America | 1989

Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.

Herbert Kühnel; H von Briesen; Ursula Dr Dietrich; Michalina Adamski; D. Mix; Lothar Biesert; R Kreutz; Andreas Immelmann; K. Henco; C. Meichsner


Nature | 1989

A highly divergent HIV-2-related isolate.

Ursula Dietrich; Michalina Adamski; Renate Kreutz; Anja Seipp; Herbert Kühnel; Helga Rübsamen-Waigmann


Archive | 1989

HIV-2 virus variants

Karsten Henco; Briesen Hagen Von; Andreas Immelmann; Herbert Kühnel; Ursula Dr Dietrich; H. Rübsamen-Waigmann; Michalina Adamski


Glycobiology | 1994

Oligosaccharide profiles of HIV-2 external envelope glycoprotein: dependence on host cells and virus isolates

Steffen Liedtke; Michalina Adamski; Rudolf Geyer; Andreas Pfützner; Helga Rübsamen-Waigmann; Hildegard Geyer


Virology | 1998

Nef Proteins of Distinct HIV-1 or -2 Isolates Differ in Their Binding Properties for HCK: Isolation of a Novel Nef Binding Factor with Characteristics of an Adaptor Protein

Thomas Karn; Björn Hock; Uwe Holtrich; Michalina Adamski; Klaus Strebhardt; Helga Rübsamen-Waigmann


Archive | 1997

Vaccine for protection against HIV infections, process for preparing same and their use as diagnostic and agent immunotherapeutic agent

Ursula Dietrich; Michalina Adamski; Hagen von Briesen; Herbert Kühnel; H. Rübsamen-Waigmann


AIDS - Forschung | 1988

Origin and serological characteristics of HIV-2 cases diagnosed in West-Germany

Lothar Biesert; Michalina Adamski; B. Selb; H. Von Briesen; D. Mix; H. E. Roscher; T. Spiegelberg; A. Valenteijn; K. Schildwächter; A. Sauer; H. W. Doerr; H. Rübsamen-Waigmann


Archive | 1990

Vaccines for protecting against infections by hiv virus;process for producing the same and their use as diagnostic and immunotherapy means.

Ursula Dietrich; Michalina Adamski; Briesen Hagen Von; Herbert Dr Kuehnel; Helga Prof Ruebsamen-Waigmann

Collaboration


Dive into the Michalina Adamski's collaboration.

Top Co-Authors

Avatar

H. Rübsamen-Waigmann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Klaus Strebhardt

Goethe University Frankfurt

View shared research outputs
Top Co-Authors

Avatar

R. Milbradt

Goethe University Frankfurt

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas Karn

Goethe University Frankfurt

View shared research outputs
Researchain Logo
Decentralizing Knowledge